Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving CIPN in Patients With Colon or Breast Cancer After End of Adj. Therapy

NCT03065478 · clinicaltrials.gov ↗

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

CIPN in Adjuvant Colon Cancer Patients
CIPN in Adjuvant Breast Cancer Patients

Interventions

DIETARY_SUPPLEMENT: OnLife

Sponsor

Swiss Medical Food AG

Collaborators

[object Object]